Pharma Stocks Sink as Trump Says 'Major' Tariffs Coming to Industry
Shares of several major pharmaceutical companies slumped Wednesday morning as President Donald Trump threatened tariffs on the industry.
Shares of several major pharmaceutical companies slumped Wednesday morning as President Donald Trump threatened tariffs on the industry.
Donald Trump tried to calm markets as traders continued to digest his sweeping tariffs.
President Donald Trump’s tariff policy continued having a dizzying effect on global markets Wednesday, causing U.S. government borrowing costs to surge while stocks saw choppy trading as China ratcheted up retaliatory tariffs.
Apple, Starbucks upgraded: Wall Street's top analyst calls
Treasury Secretary Scott Bessent on Wednesday attributed the chaos in the bond market to some "very large leveraged players" that are experiencing losses but said it is "nothing systemic."
(Bloomberg) -- Short sellers, or traders who wager on share price declines, are up $159 billion in paper profits over just six trading days after an escalating trade war sent the US stock market plummeting down more than 10%. The biggest market drawdown since 2022 on President Donald Trump’s pronouncement of sweeping worldwide tariffs made bets against an exchange traded fund tracking the S&P 500 Index, known as SPY, the most profitable short bet in that timeframe, according to data from S3 Part
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.